A proposed relationship among energy availability, proliferation, differentiation and apoptosis
Suggested URL: /cancer-cellular-energy/ | Parent: Human Health and the ACE Pathway
Why Consider Cellular Energy in Cancer?
Cancer cells clearly possess sufficient metabolic capacity for survival and proliferation. The ACE hypothesis therefore does not simply propose that cancer represents a generalized lack of energy.
A more specific question is whether the availability or distribution of usable cellular energy may be inadequate for other energy-dependent functions, including normal differentiation, cellular organization or execution of apoptosis.
A Published Hypothesis
Published work has proposed that enhancing the ACE Pathway could alter the balance between continued tumor-cell proliferation and energy-dependent cellular programs such as apoptosis.
This is a hypothesis. The publications provide a rationale for experimental testing but do not establish ACE enhancement as an effective cancer treatment.
A More Precise Research Question
Rather than asking whether “more energy treats cancer,” a more useful question is:
Does enhancement of the proposed ACE Pathway alter proliferation, differentiation, metabolism or apoptosis differently in malignant and non-malignant cells?
This question can be tested in cell culture without requiring prior acceptance of KELEA.
Experimental Roadmap
A basic study could compare matched malignant and non-malignant cells exposed to:
untreated control conditions
standardized activated water or another defined Enerceutial condition
sham-treated controls
conventional positive controls where appropriate
Predefined endpoints could include proliferation, viability, apoptosis markers, differentiation markers, mitochondrial function, membrane potential and other conventional cellular measurements.
Enercel® and Other Clinical Observations
Published reports involving Enercel® and other approaches were interpreted within the ACE framework and include observations in a diverse range of illnesses.
Such reports can provide hypotheses and candidate interventions, but they should be separated from controlled evidence of cancer efficacy. Enercel therefore deserves its own page as a candidate Enerceutial and as part of the historical development of the ACE concept.
Relationship to the Broader ACE Model
Cancer illustrates why the ACE Pathway should not be reduced to a simple substitute for ATP.
A cell may have adequate energy for one activity—such as proliferation—while failing to execute another highly organized function. The relevant variable may therefore be the amount, location, timing or form of usable energy, rather than total metabolic output alone.
Clinical Caution
Nothing on this page should be interpreted as advice to delay or replace established cancer diagnosis or treatment. The purpose is to define a published hypothesis and the experiments needed to determine whether it has biological or clinical validity.
Selected Published Sources
Martin WJ. Cancer Is Treatable via the Alternative Cellular Energy (ACE) Pathway. Journal of Cancer Therapy. 2017.
https://www.scirp.org/pdf/JCT_2017122714322029.pdf
Martin WJ. Homeopathy as a Misnomer for Activation of the Alternative Cellular Energy Pathway: Evidence for the Therapeutic Benefits of Enercel® in a Diverse Range of Clinical Illnesses.